FDA Warns Lake Forest-Based Generic Drug Company Akorn, Inc. About Unsterile Distribution Processes at Plants
Manufacturing problems involving quality and aseptic technique at Akorn Inc.’s New Jersey plant “pose a risk to patients,” according to U.S. Food & Drug Administration (FDA) regulators. The Lake Forest, Illinois-based generic drug manufacturer received […]